Search research articles
Contact Us
Filters
Showing results (131-140 of 139) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 139 results.
Journal of Magnetic Resonance Imaging : JMRI
|
March 30, 2019
Translating preclinical MRI methods to clinical oncology
David A Hormuth, Anna G Sorace, John Virostko, et al.
RSC Medicinal Chemistry
|
September 10, 2025
Targeting Tumor-Associated Hypoxia with Bioreductively Activatable Prodrug Conjugates Derived from Dihydronaphthalene, Benzosuberene, and Indole-based Inhibitors of Tubulin Polymerization
Zhe Shi, Rajsekhar Guddneppanavar, Blake A Winn, et al.
Cancers
|
September 9, 2022
Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment
Li Liu, Regan Schuetze, Jeni L Gerberich, et al.
Journal of Natural Products
|
March 21, 2020
Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia
Blake A Winn, Laxman Devkota, Bunnarack Kuch, et al.
Cancers
|
March 13, 2025
Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Hashini I Wanniarachchi, Regan Schuetze, Yuling Deng, et al.
Cancer Letters
|
September 2, 2015
The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts
Tracy E Strecker, Samuel O Odutola, Ramona Lopez, et al.
Journal of Natural Products
|
September 11, 2013
Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent
Mallinath B Hadimani, Matthew T Macdonough, Anjan Ghatak, et al.
Magnetic Resonance in Medicine
|
September 21, 2022
The future of MRI in radiation therapy: Challenges and opportunities for the MR community
Rosie J Goodburn, Marielle E P Philippens, Thierry L Lefebvre, et al.
International Journal of Radiation Biology
|
November 23, 2006
Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
James L Tatum, Gary J Kelloff, Robert J Gillies, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 139) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 139 results.
Journal of Magnetic Resonance Imaging : JMRI
|
March 30, 2019
Translating preclinical MRI methods to clinical oncology
David A Hormuth, Anna G Sorace, John Virostko, et al.
RSC Medicinal Chemistry
|
September 10, 2025
Targeting Tumor-Associated Hypoxia with Bioreductively Activatable Prodrug Conjugates Derived from Dihydronaphthalene, Benzosuberene, and Indole-based Inhibitors of Tubulin Polymerization
Zhe Shi, Rajsekhar Guddneppanavar, Blake A Winn, et al.
Cancers
|
September 9, 2022
Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment
Li Liu, Regan Schuetze, Jeni L Gerberich, et al.
Journal of Natural Products
|
March 21, 2020
Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia
Blake A Winn, Laxman Devkota, Bunnarack Kuch, et al.
Cancers
|
March 13, 2025
Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Hashini I Wanniarachchi, Regan Schuetze, Yuling Deng, et al.
Cancer Letters
|
September 2, 2015
The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts
Tracy E Strecker, Samuel O Odutola, Ramona Lopez, et al.
Journal of Natural Products
|
September 11, 2013
Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent
Mallinath B Hadimani, Matthew T Macdonough, Anjan Ghatak, et al.
Magnetic Resonance in Medicine
|
September 21, 2022
The future of MRI in radiation therapy: Challenges and opportunities for the MR community
Rosie J Goodburn, Marielle E P Philippens, Thierry L Lefebvre, et al.
International Journal of Radiation Biology
|
November 23, 2006
Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
James L Tatum, Gary J Kelloff, Robert J Gillies, et al.
Page
of 14